Express Scripts recently announced the purchase of eviCore, a leading medical benefits management firm, for $3.6 billion. The merger has the potential to be the first comprehensive care management offering.
This paper explores the growing trend of clinical pathways for symptom management—including how they can be applied across cancer care and the positive downstream effects of pathways for symptom control—by examining the implementation of symptom management clinical pathways at one treatment center.
Rationale for the Development of Clinical Pathways and an Overview of the Clinical Pathways Office at the Seattle Cancer Care Alliance
This paper examines the establishment of the Seattle Cancer Care Alliance Clinical Pathways Office, as well as the goals of clinical pathway development from the standpoint of a regional hospital system.
Pharmaceutical Manufacturer Responses to Health Care Professional and Clinical Pathway Developer Requests for Medical Information
The purpose of this article is to describe the role of the MIS and MSL in responding to requests from HCPs and clinical pathways developers for up-to-date, evidence-based product information to enable them to make informed decisions about patient care.
Using principles of pathways, the paper explores a framework for a restructuring health care that aligns design, delivery, governance, and administration to reconnect providers, caregivers, and patients; improve quality and safety; and continue to lower cost of care.
Patient-Reported Outcome Measurement in Clinical Practice: Overcoming Challenges to Continue Progress
The authors share their experiences with implementing PRO collection and discuss the key considerations for success, including appropriate measure selection, achieving buy-in from health care providers, and utilizing PRO data in clinical practice.
In Defense of Meaningful Use: The Potential of Electronic Health Records Systems to Support Value-Based Care
An enlarged historical perspective makes apparent the fundamental and positive transformation of health care initiated by the Meaningful Use program.
In this article, the author discusses the most prominent value frameworks that have been recently developed and compare each of their methods for defining value.
Authors examine different cost control levers the government could use to affect drug pricing and have an impact on treatments selected within clinical pathways.
The essential role of patient navigation and care coordination services in helping patients to adhere to their treatment plans.